Stryker Corp. (NYSE:SYK)’s share price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $121.60 and last traded at $121.06, with a volume of 477,120 shares. The stock had previously closed at $121.09.

SYK has been the subject of a number of research reports. Goldman Sachs Group Inc. lifted their target price on shares of Stryker Corp. from $107.00 to $119.00 in a research report on Friday, April 8th. Stifel Nicolaus lifted their target price on shares of Stryker Corp. from $92.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, March 28th. Canaccord Genuity lifted their target price on shares of Stryker Corp. from $76.00 to $82.00 and gave the stock a “buy” rating in a research report on Monday, March 28th. Brean Capital reissued a “buy” rating on shares of Stryker Corp. in a research report on Thursday, April 21st. Finally, Leerink Swann reissued a “buy” rating and issued a $125.00 price objective (up previously from $111.00) on shares of Stryker Corp. in a research report on Thursday, April 21st. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and twelve have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $109.23.

The company has a market cap of $45.73 billion and a PE ratio of 28.62. The stock’s 50 day moving average is $115.28 and its 200-day moving average is $105.34.

Stryker Corp. (NYSE:SYK) last announced its quarterly earnings results on Wednesday, April 20th. The medical technology company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.20 by $0.04. The company had revenue of $2.50 billion for the quarter, compared to analyst estimates of $2.47 billion. During the same quarter last year, the business earned $1.11 EPS. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. Equities analysts predict that Stryker Corp. will post $5.77 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Thursday, June 30th will be issued a dividend of $0.38 per share. The ex-dividend date of this dividend is Tuesday, June 28th. This represents a $1.52 annualized dividend and a yield of 1.24%.

In other Stryker Corp. news, Director Louise Francesconi sold 4,985 shares of the stock in a transaction that occurred on Friday, April 22nd. The stock was sold at an average price of $108.93, for a total transaction of $543,016.05. Following the transaction, the director now owns 25,142 shares in the company, valued at $2,738,718.06. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Ronda E. Stryker sold 12,000 shares of the stock in a transaction that occurred on Monday, April 11th. The shares were sold at an average price of $108.46, for a total value of $1,301,520.00. Following the transaction, the director now owns 193,142 shares in the company, valued at approximately $20,948,181.32. The disclosure for this sale can be found here.

Several large investors recently made changes to their positions in SYK. Bragg Financial Advisors Inc increased its stake in shares of Stryker Corp. by 0.3% in the fourth quarter. Bragg Financial Advisors Inc now owns 10,900 shares of the medical technology company’s stock valued at $1,013,000 after buying an additional 35 shares during the last quarter. Essex Financial Services Inc. increased its stake in shares of Stryker Corp. by 0.3% in the fourth quarter. Essex Financial Services Inc. now owns 11,338 shares of the medical technology company’s stock valued at $1,054,000 after buying an additional 30 shares during the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC increased its stake in shares of Stryker Corp. by 3.8% in the fourth quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 11,356 shares of the medical technology company’s stock valued at $1,055,000 after buying an additional 420 shares during the last quarter. Brown Advisory Securities LLC increased its stake in shares of Stryker Corp. by 0.8% in the fourth quarter. Brown Advisory Securities LLC now owns 12,761 shares of the medical technology company’s stock valued at $1,186,000 after buying an additional 107 shares during the last quarter. Finally, Victory Capital Management Inc. increased its stake in shares of Stryker Corp. by 50.0% in the fourth quarter. Victory Capital Management Inc. now owns 13,405 shares of the medical technology company’s stock valued at $1,246,000 after buying an additional 4,467 shares during the last quarter.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.